Amgen, US0311621009

Amgen stock heads into earnings week after dividend update

Published on 10/31/2026 at 10:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Amgen stock enters a key reporting week after the company declared its fourth-quarter dividend. Third-quarter results are due on November 3.

Amgen enters earnings week

  • Amgen declared a fourth-quarter dividend of 2.52 US dollars per share, payable on December 11 to shareholders of record on November 20.
  • The company will release third-quarter 2026 results after U.S. markets close on November 3, followed by a 4:30 p.m. Eastern Time conference call.
Amgen, US0311621009, Illustration mit AI erstellt.

Amgen enters the new week with two investor-relevant announcements ahead of its third-quarter report. The company declared a fourth-quarter dividend and set November 3 for the release of its results.

Dividend and results date set

Amgen's board declared a dividend of 2.52 US dollars per share on October 27, according to Yahoo Finance. The payment is scheduled for December 11, with shareholders recorded at the close of business on November 20 eligible for the distribution.

On October 28, Amgen announced that it will publish third-quarter 2026 financial results after the close of U.S. markets on Tuesday, November 3. The release will be followed by a conference call at 4:30 p.m. Eastern Time, the company said in a PR Newswire announcement.

Next test is quarterly execution

The earnings release will give investors a fresh read on revenue, profitability and demand across Amgen's portfolio. Management's conference call may also shape expectations for the remainder of 2026 and the company's development pipeline.

Amgen stock traded at 416.68 euros on Lang & Schwarz at 09:57 CET on Saturday, October 31, 2026. Investors can follow the real-time quote of Amgen stock.

Amgen stock at a glance

  • Company: Amgen Inc.
  • ISIN: US0311621009
  • Trading venue: Lang & Schwarz
  • Quote: 416.68 euros on October 31, 2026, at 09:57 CET

The broader U.S. market backdrop is available through current S&P 500 market coverage.

More news and analyses on Amgen stock

Disclaimer...
en | US0311621009 | AMGEN | boerse | 70437884 |